Trial intelligence / Profile preview

Leuprolide acetate pretreatment in endometriosis IVF cycles

NCT00621179Phase 4Completed

Sponsor
CCRM Fertility
Start
Mar 2003
Primary completion
Aug 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of leuprolide in endometriosis (4 arms), sponsored by CCRM Fertility. Primary endpoint: Patients Who Responded to Controlled Ovarian Hyperstimulation at 6.5 weeks. Started Mar 2003; status: completed.

02

Drugs

leuprolide
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT00621179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00621179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call